ESAB Corporation
NYSE:ESABManufacturing - Metal Fabrication
+$4.24 today
- Market cap
- $4.92B
- Beta
- 1.15
- P/E (TTM)
- 30.4
- EPS (TTM)
- $3.40
- Dividend yield
- 0.39%
Volume 0.53M
Average 0.71M
ESAB Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
ESAB CorporationNYSE: ESAB
Capital Expenditures · Q3 FY2026 · quarter ended Oct 2026
Capital expenditures growth accelerates
Q3 FY2026 capital expenditures of $18.25M (cash outflow) rose 63.3% year over year, ahead of the +32.4% change in trailing-twelve-month capital expenditures. Sequentially, it rose 2.9% from the prior quarter. Over 3 fiscal years it compounded at +5.5% a year.
Context
- Capital expenditures amounted to 1.7% of revenue in FY2025, down 0.2 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +63.3% holds above the trailing-twelve-month pace of +32.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (47.29M) USD
- Year-over-year change
- +8.7%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (47.29M) | +8.7% |
| FY2024 | 2024-12-31 | (51.78M) | -7.5% |
| FY2023 | 2023-12-31 | (48.18M) | -19.7% |
| FY2022 | 2022-12-31 | (40.24M) | -13.1% |
| FY2021 | 2021-12-31 | (35.58M) | — |
Capital Expenditures vs competitors
How ESAB compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +32.4% is the highest of 10, against a peer median of -19.7%.
- Capital expenditures amounts to 2.2% of revenue for ESAB, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.78B USD | -28.5% | -6.7% | 13.6% | |
| LTM Jun 2026 | €1.74B EUR | +22.7% | -0.2% | 11.1% | |
| LTM Jun 2026 | $351.16M USD | -52.5% | +15.6% | 10.4% | |
| LTM Jun 2026 | $289.68M USD | -10.3% | +4.2% | 3.3% | |
| LTM Jun 2026 | $277.12M USD | -45.1% | -14.4% | 5.4% | |
| LTM Jun 2026 | $126.35M USD | -13.1% | +1.3% | 2.9% | |
| LTM Jul 2026 | $77.8M USD | -19.7% | -16.4% | 1.6% | |
| LTM Sep 2026 | $69.72M USD | -61.2% | +37.2% | 2.9% | |
| LTM Oct 2026 | $69.33M USD | +32.4% | +5.5% | 2.2% | |
| LTM Jun 2026 | $33.3M USD | +13.7% | -19.5% | 1.4% | |
| Peer median (excluding ESAB) | — | -19.7% | -0.2% | 3.3% | |
Competitors are the stored peer set for ESAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 238.68M | 228.01M | 216.07M | 270.75M | 233.23M |
| Depreciation & Amortization | 75.9M | 65.98M | 69.7M | 66.79M | 84.11M |
| Deferred Income Tax | (8.64M) | (20.2M) | (25.41M) | (2.6M) | (35.66M) |
| Stock-Based Compensation | 6.27M | 12.96M | 16.12M | 19.78M | 16.94M |
| Change in Working Capital | (49.81M) | (65.47M) | 52.53M | (14.36M) | (35.26M) |
| Accounts Receivables | (67.85M) | (8.14M) | (6.01M) | (4.85M) | (40.01M) |
| Inventory | (117.35M) | (10.07M) | 17.96M | (22.5M) | (5.57M) |
| Accounts Payables | 114.5M | (28.79M) | (19.82M) | 31.86M | 6.69M |
| Other Working Capital | 20.89M | (18.47M) | 60.39M | (18.88M) | 3.64M |
| Other Non-Cash Items | (11.66M) | (6.93M) | 1.48M | 15.04M | (2.78M) |
| Operating Cash Flow | 250.74M | 214.36M | 330.49M | 355.4M | 260.57M |
| Capital Expenditures | (35.58M) | (40.24M) | (48.18M) | (51.78M) | (47.29M) |
| Acquisitions (Net) | (4.89M) | (149.03M) | (18.67M) | (149.86M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 5.2M | 4.85M | 4.6M | (4.06M) | (432.6M) |
| Investing Cash Flow | (35.27M) | (184.42M) | (62.24M) | (205.7M) | (479.88M) |
| Debt Repayment | 673K | 1.22B | (202.5M) | 65.5M | 158.57M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | (6.05M) | (13.34M) | (16.99M) | (21.91M) |
| Other Financing Activities | (222.24M) | (1.21B) | (3.88M) | (16.83M) | (22.95M) |
| Financing Cash Flow | (221.57M) | 7.56M | (219.72M) | 31.67M | 113.7M |
| Effect of Forex Changes | (1.9M) | (6.68M) | (18.56M) | (34.02M) | 42.12M |
| Net Change in Cash | (8M) | 30.82M | 29.98M | 147.36M | (63.5M) |
| Free Cash Flow | 215.15M | 174.12M | 282.32M | 303.62M | 213.28M |
ESAB Corporation
NYSE:ESAB
Intrinsic Alpha fair value
Locked
Current Price
$79.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.